CONFORMED
SECURITIES AND EXCHANGE COMMISSION
Washington, D.C. 20549
FORM 8-K
CURRENT REPORT
Pursuant to Section 13 or 15(d) of the
Securities Exchange Act of 1934
___________________
Date of Report (Date of earliest event reported) May 14, 1997
BIOCONTROL TECHNOLOGY, INC.
(Exact name of registrant as specified in its charter)
Pennsylvania 0-10822
25-1229323
(State of other jurisdiction (Commission File
Number) (IRS Employer
of incorporation)
Identification No.)
300 Indian Springs Road, Indiana, Pennsylvania 15701
(Address of principal executive offices) (Zip Code)
Registrant's telephone number, including area code (412) 349-1811
_________________________________________________________________
(Former name or former address,
if changes since last report.)
Item 1. Change in Control of Registrant.
Not applicable.
Item 2. Acquisition or Disposition of Assets.
Not applicable.
Item 3. Bankruptcy or Receivership.
Not applicable.
Item 4. Changes in Registrant's Certifying Accountant
Not applicable.
Item 5. Other Events.
On May 14, 1997, Biocontrol Technology, Inc.
(NASDAQ:BICO) announced that effective immediately, its top
executives will waive their salaries until more significant sales
of Biocontrol's products have been generated.
Item 6. Resignation of Registrant's Directors.
Not Applicable
Item 7. Financial Statement, Pro Forma Financial Information
and Exhibits.
(a) Financial Statements and Businesses Acquired - Not
Applicable.
(b) Pro Forma Financial Information - Not Applicable.
(c) Exhibits-Press Release
SIGNATURES
Pursuant to the requirement of the Securities Exchange Act
of 1934, the Registrant has duly caused this Report to be signed
on its behalf by the undersigned hereunto duly authorized.
BIOCONTROL TECHNOLOGY, INC.
by /s/ Fred E. Cooper
Fred E. Cooper, CEO
DATED: May 14, 1997
BICO
BIOCONTROL TECHNOLOGY, INC.
2275 Swallow Hill Road, Bldg. 2500
Pittsburgh, PA 15220
Press Release
Release: Immediate
For More Information, Call:
Investors Media
Diane McQuaide
Susan Taylor
1.412.429.0673 phone
1.412.279.9455 phone
1.412.279.9690 fax
1.412.279.9447 fax
BIOCONTROL EXECUTIVES WAIVE SALARIES
Pittsburgh, PA - May 14, 1997 - Biocontrol Technology, Inc.
(Nasdaq:BICO) announced today that, effective immediately, its
top executives will waive their salaries until more significant
sales of Biocontrol's products have been generated.
Fred E. Cooper, chief executive officer of Biocontrol,
stated, "The Company's executives feel that it is in the best
interest of the Company and the shareholders for us to take no
pay for awhile, as we have done periodically over the years when
the situation warranted it. We have cut back other expenses and
overhead and will continue to look for other possible areas to
pull back."
"Several of our products are beginning to do quite well,"
continued Cooper, "and we believe that sales will soon show a
noticeable increase both here in the US and in China where we
have just begun to open a market through our joint venture,
Superpower-BICO International Group, Inc."
Biocontrol Technology, Inc. has its corporate offices in
Pittsburgh, PA and is involved in the development and manufacture
of biomedical devices and environmental products.
